OHRP has experienced an unprecedented exodus of ethics expertise, raising concerns about its ability to effectively protect ...

Americans who have high-risk exposures to Ebola in the current outbreak in Central Africa will have access to an experimental ...

The listening session, held on the FDA’s White Oak Campus, featured 17 speakers representing patient groups, drug companies, ...

The Supreme Court unanimously ruled that Hikma Pharmaceutical did not infringe patents held by Amarin in a decision with ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. NEW ORLEANS — A senior ...

Biomedical researchers and policy experts decried the change when it was proposed this spring. STAT’s Anil Oza has the latest ...

A senior NIH scientist and his research fellow were charged with smuggling vials of deactivated mpox virus into the country ...

The French pharma firm Servier is buying an experimental muscular dystrophy drug from Edgewise Therapeutics for $1.55 billion ...

For pancreatic cancer patients, the surge in interest for an exciting new drug is leaving them fearful about when they might ...

A compound named “substance God help me” by its longtime champion could benefit from RFK Jr.'s favorable views on using ...

Drugmakers and patient groups asked the FDA to pause former commissioner Marty Markary's National Priority Voucher drug ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. You’re reading the web ...